Cambridge (UK) tech start-up, Repositive, has introduced new features to its Cancer Models Platform, responding to feedback from the platform’s growing user base. The platform provides oncology researchers with a holistic, searchable, comparable view of existing cancer models, whilst providing Contract Research Organisations (CROs) - the providers of the cancer models - with a tool to market, manage and analyse their models.